机译:NLG919 /环糊精络合和抗癌治疗益处与紫杉醇相结合的潜在免疫疗法
Chinese Acad Sci Ctr Drug Delivery Syst Shanghai Inst Mat Med Shanghai 201210 Peoples R China;
Chinese Acad Sci Ctr Drug Delivery Syst Shanghai Inst Mat Med Shanghai 201210 Peoples R China;
Chinese Acad Sci Ctr Drug Delivery Syst Shanghai Inst Mat Med Shanghai 201210 Peoples R China;
Chinese Acad Sci Ctr Drug Delivery Syst Shanghai Inst Mat Med Shanghai 201210 Peoples R China;
Chinese Acad Sci Ctr Drug Delivery Syst Shanghai Inst Mat Med Shanghai 201210 Peoples R China;
Univ Bradford Fac Life Sci Inst Canc Therapeut Bradford BD7 1DP W Yorkshire England;
Chinese Acad Sci Ctr Drug Delivery Syst Shanghai Inst Mat Med Shanghai 201210 Peoples R China;
Chinese Acad Sci Ctr Drug Delivery Syst Shanghai Inst Mat Med Shanghai 201210 Peoples R China;
Cyclodextrins; NLG919; Solubility enhancement; Paclitaxel; IDO-1 combination immunochemotherapy;
机译:NLG919 /环糊精络合和抗癌治疗益处与紫杉醇相结合的潜在免疫疗法
机译:NLG919 /环糊精络合和抗癌治疗益处与紫杉醇相结合的潜在免疫疗法
机译:红色番石榴提取物的抗癌治疗益处作为与多柔比星或针对三重阴性乳腺癌细胞的靶向治疗组合的潜在疗法
机译:环糊精/双醋瑞因包合物:治疗药物的传递工具
机译:基于嘧啶的杂环作为潜在抗癌剂的设计与合成,具有组合化疗潜力或靶向一种碳代谢抑制和抗机会性药物
机译:红番石榴提取物的抗癌治疗作用与阿霉素或靶向治疗结合用于三阴性乳腺癌细胞的潜在治疗
机译:HSP90抑制剂和癌症耐药性:HSP90抑制剂和其他抗癌药物联合疗法的潜在益处